Articles with public access mandates - Ming Ta Michael LeeLearn more
Not available anywhere: 7
Genome-wide association study in NSAID-induced acute urticaria/angioedema in Spanish and Han Chinese populations
JA Cornejo-García, LB Liou, N Blanca-López, I Doña, CH Chen, YC Chou, ...
Pharmacogenomics 14 (15), 1857-1869, 2013
Mandates: Government of Spain
Population differences in S-warfarin pharmacokinetics among African Americans, Asians and whites: their influence on pharmacogenetic dosing algorithms
K Kubo, M Ohara, M Tachikawa, LH Cavallari, MTM Lee, MS Wen, ...
The pharmacogenomics journal 17 (6), 494, 2017
Mandates: US National Institutes of Health, American Heart Association
Differences in Warfarin Pharmacodynamics and Predictors of Response Among Three Racial Populations
M Ohara, Y Suzuki, S Shinohara, IY Gong, CL Schmerk, RG Tirona, ...
Clinical pharmacokinetics, 1-13, 2019
Mandates: American Heart Association
Nanoprobe-based genetic testing
Y Zu, MH Tan, B Chowbay, SC Lee, H Yap, MTM Lee, LS Lu, CP Chang, ...
Nano Today 9 (2), 166-171, 2014
Mandates: A*Star, Singapore, UK Medical Research Council
Genome-Wide Association Analysis Across 16,956 Patients Identifies a Novel Genetic Association Between BMP6, NIPAL1, CNGA1 and Spondylosis
Y Zhang, RA Grant, MK Shivakumar, M Zaleski, N Sofoluke, JR Slotkin, ...
Spine, 2020
Mandates: US National Institutes of Health
Epistatic analysis of NSAIDs hypersensitivity using high performance computing
A Upton, O Trelles, MTM Lee, LB Liou, M Blanca, JA Cornejo-Garcia, ...
2015 International Workshop on Artificial Immune Systems (AIS), 1-7, 2015
Mandates: US National Institutes of Health, Government of Spain
Correlations between the enantio-and regio-selective metabolisms of warfarin
H Takahashi, M Ohara, S Shibata, MTM Lee, LH Cavallari, EA Nutescu, ...
Pharmacogenomics 18 (2), 133-142, 2017
Mandates: American Heart Association, Government of Italy
Available somewhere: 51
The landscape of cancer genes and mutational processes in breast cancer
PJ Stephens, PS Tarpey, H Davies, P Van Loo, C Greenman, DC Wedge, ...
Nature 486 (7403), 400-404, 2012
Mandates: US National Institutes of Health, Research Foundation (Flanders), National …
Estimation of the warfarin dose with clinical and pharmacogenetic data
International Warfarin Pharmacogenetics Consortium
New England Journal of Medicine 360 (8), 753-764, 2009
Mandates: US National Institutes of Health
Pan-cancer analysis of whole genomes
I The, TPCA of Whole, Genomes Consortium
Nature 578 (7793), 82, 2020
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing
JA Johnson, L Gong, M Whirl‐Carrillo, BF Gage, SA Scott, CM Stein, ...
Clinical Pharmacology & Therapeutics 90 (4), 625-629, 2011
Mandates: US National Institutes of Health, Swedish Research Council
Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for pharmacogenetics‐guided warfarin dosing: 2017 update
JA Johnson, KE Caudle, L Gong, M Whirl‐Carrillo, CM Stein, SA Scott, ...
Clinical Pharmacology & Therapeutics 102 (3), 397-404, 2017
Mandates: US National Institutes of Health, Swedish Research Council, UK Medical …
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups
NA Limdi, M Wadelius, L Cavallari, N Eriksson, DC Crawford, MTM Lee, ...
Blood, The Journal of the American Society of Hematology 115 (18), 3827-3834, 2010
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process
KE Caudle, TE Klein, JM Hoffman, DJ Müller, M Whirl-Carrillo, L Gong, ...
Current drug metabolism 15 (2), 209, 2014
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations
CG Boer, K Hatzikotoulas, L Southam, L Stefánsdóttir, Y Zhang, ...
Cell, 2021
Mandates: UK Medical Research Council, National Institute for Health Research, UK
Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen‐B Genotype and Allopurinol Dosing
MS Hershfield, JT Callaghan, W Tassaneeyakul, T Mushiroda, CF Thorn, ...
Clinical Pharmacology & Therapeutics 93 (2), 153-158, 2013
Mandates: US National Institutes of Health
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing
KE Caudle, AE Rettie, M Whirl-Carrillo, LH Smith, S Mintzer, MTM Lee, ...
Clinical Pharmacology & Therapeutics 96 (5), 542-548, 2014
Mandates: US National Institutes of Health
Global Biobank Meta-analysis Initiative: Powering genetic discovery across human disease
W Zhou, M Kanai, KHH Wu, H Rasheed, K Tsuo, JB Hirbo, Y Wang, ...
Cell Genomics 2 (10), 100192, 2022
Mandates: US National Institutes of Health, US Department of Veterans Affairs, UK …
CYP2D6 Genotype and Adjuvant Tamoxifen: Meta‐Analysis of Heterogeneous Study Populations
MA Province, MP Goetz, H Brauch, DA Flockhart, JM Hebert, R Whaley, ...
Clinical Pharmacology & Therapeutics 95 (2), 216-227, 2014
Mandates: US National Institutes of Health, German Research Foundation, Cancer …
Variant GADL1 and Response to Lithium Therapy in Bipolar I Disorder
CH Chen, CS Lee, MTM Lee, WC Ouyang, CC Chen, MY Chong, JY Wu, ...
New England Journal of Medicine 370 (2), 119-128, 2014
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program